Skip to content
DraconiticResearch
Search Sources API
201,683 studies31 sourcesUpdated 11 min ago
Peer-reviewedCC BY-NC 4.0Journal of Pain Research

Effect of Transcutaneous Electrical Acupoint Stimulation on Postmenopausal Osteoporosis-Related Pain: Study Protocol for a Randomized, Sham-Controlled Trial

5 affiliations
  1. 1Department of Rehabilitation Medicine, Linping Campus, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People’s Republic of China
  2. 2Department of Acupuncture, Hangzhou Linping TCM Hospital, Hangzhou, Zhejiang, People’s Republic of China
  3. 3The Third Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, People’s Republic of China
  4. 4Department of Acupuncture and Moxibustion, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, People’s Republic of China
  5. 5Department of Traditional Chinese Medicine, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, People’s Republic of China

Abstract

Introduction: Pain is a common symptom among postmenopausal women with osteoporosis and can substantially impair physical function and quality of life. Transcutaneous electrical acupoint stimulation (TEAS) has been increasingly used for pain management; however, evidence regarding its effectiveness in postmenopausal osteoporosis-related pain remains limited. This study aims to evaluate the efficacy and safety of TEAS in this population.

Methods and Analysis: This prospective, single-center, participant-and assessor-blinded, randomized, sham-controlled trial will enroll 146 postmenopausal women with osteoporosis-related pain. Participants will be randomly assigned to either the TEAS group or the sham TEAS group in a 1:1 ratio. All participants will receive oral calcitriol soft capsules (0.25 μg/day) for 8 weeks. The TEAS group will receive stimulation at bilateral Pishu (BL20), Shenshu (BL23), Zusanli (ST36), and Sanyinjiao (SP6) once every other day for 8 weeks, while the sham TEAS group will receive identical procedures without therapeutic electrical stimulation. The primary outcome will be the change in visual analogue scale (VAS) score from baseline to week 8. Secondary outcomes will include changes in VAS scores from baseline to weeks 4 and 12, pain responder rate, lumbar spine bone mineral density (BMD), serum osteoprotegerin (OPG), serum calcium, serum neuropeptide Y (NPY), and quality of life assessed using the Short Form-36 (SF-36). Safety outcomes will also be evaluated. Data analysis will follow the intention-to-treat principle.

Ethics/Dissemination: The study has been approved by the Medical Ethics Committee of Linping Campus, Second Affiliated Hospital, Zhejiang University School of Medicine (4 June 2026; approval No.2026-011). Findings will be disseminated through peer-reviewed publications and academic conferences.

Trial Registration: Registered in the International Traditional Medicine Clinical Trial Registry (ITMCTR) with the registration number ITMCTR2026002224 (https://itmctr.ccebtcm.org.cn/, 31 August 2026).

Related

  1. Efficacy of diadynamic currents versus transcutaneous electrical nerve stimulation for transcutaneous tibial nerve stimulation in subjects with overactive bladder syndrome: A double-blind randomized controlled trial
    Jaya Shanker Tedla, Sneha Latha Lalaji, Ajaya Kumar Midde +8
    PLOS OnePeer-reviewedCC BY 4.0NeuroscienceClinical trials & evidence synthesisPLOS
  2. Transcutaneous electrical acupoint stimulation versus sham stimulation and dexamethasone versus amisulpride for preventing postoperative nausea and vomiting after laparoscopic gynecologic surgery: protocol for a randomized 2 × 2 factorial trial
    Yu Li, Jun Zhang, Yu Xu +5
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyCrossref
  3. Combined transcutaneous electrical nerve stimulation and low-level laser photobiomodulation for postoperative pain after cesarean section: A randomized controlled trial
    Alane Macatrão Pires de Holanda Araújo Sena, Ivan Daniel Bezerra Nogueira, Kássio Rafael Rocha de Sena +2
    PLOS OnePeer-reviewedCC BYFull textCardiovascular medicinePhysiologyPLOSEurope PMC
  4. Transcutaneous Electrical Acupoint Stimulation Combined with General Anesthesia in Minimally Invasive Surgery for Lung Cancer: A Randomized, Patient- and Assessor-Blinded, Sham-Controlled Trial
    Yunxiao Zhang, Wanpu Yan, Jin Wei +4
    Journal of Clinical MedicinePeer-reviewedCC BY 4.0General medicineCrossref
  5. Efficacy and neural mechanisms of transcutaneous auricular vagus nerve stimulation for chronic insomnia: a study protocol for a randomized controlled trial
    Menghan Feng, Qin Liu, Xin Chen +3
    Frontiers in psychiatryPeer-reviewedCC BYFull textPsychiatry & mental healthEurope PMC
BibTeX
@article{yan2026effect,
  title = {{Effect of Transcutaneous Electrical Acupoint Stimulation on Postmenopausal Osteoporosis-Related Pain: Study Protocol for a Randomized, Sham-Controlled Trial}},
  author = {Sisi Yan and Xin Wang and Fangfang Pan and Wenqin Ni and Ning Luo and Gehao Hu and Xiaoyi Qin and Chaoer Ding and Chao Lu and Nisang Chen},
  journal = {Journal of Pain Research},
  year = {2026},
  month = nov,
  doi = {10.2147/jpr.s652933},
  url = {https://doi.org/10.2147/jpr.s652933},
  note = {CC BY-NC 4.0},
}
RIS
TY  - JOUR
TI  - Effect of Transcutaneous Electrical Acupoint Stimulation on Postmenopausal Osteoporosis-Related Pain: Study Protocol for a Randomized, Sham-Controlled Trial
AU  - Sisi Yan
AU  - Xin Wang
AU  - Fangfang Pan
AU  - Wenqin Ni
AU  - Ning Luo
AU  - Gehao Hu
AU  - Xiaoyi Qin
AU  - Chaoer Ding
AU  - Chao Lu
AU  - Nisang Chen
PY  - 2026
DA  - 2026/11/01
JO  - Journal of Pain Research
DO  - 10.2147/jpr.s652933
UR  - https://doi.org/10.2147/jpr.s652933
AB  - Introduction: Pain is a common symptom among postmenopausal women with osteoporosis and can substantially impair physical function and quality of life. Transcutaneous electrical acupoint stimulation (TEAS) has been increasingly used for pain management; however, evidence regarding its effectiveness in postmenopausal osteoporosis-related pain remains limited. This study aims to evaluate the efficacy and safety of TEAS in this population.  Methods and Analysis: This prospective, single-center, participant-and assessor-blinded, randomized, sham-controlled trial will enroll 146 postmenopausal women with osteoporosis-related pain. Participants will be randomly assigned to either the TEAS group or the sham TEAS group in a 1:1 ratio. All participants will receive oral calcitriol soft capsules (0.25 μg/day) for 8 weeks. The TEAS group will receive stimulation at bilateral Pishu (BL20), Shenshu (BL23), Zusanli (ST36), and Sanyinjiao (SP6) once every other day for 8 weeks, while the sham TEAS group will receive identical procedures without therapeutic electrical stimulation. The primary outcome will be the change in visual analogue scale (VAS) score from baseline to week 8. Secondary outcomes will include changes in VAS scores from baseline to weeks 4 and 12, pain responder rate, lumbar spine bone mineral density (BMD), serum osteoprotegerin (OPG), serum calcium, serum neuropeptide Y (NPY), and quality of life assessed using the Short Form-36 (SF-36). Safety outcomes will also be evaluated. Data analysis will follow the intention-to-treat principle.  Ethics/Dissemination: The study has been approved by the Medical Ethics Committee of Linping Campus, Second Affiliated Hospital, Zhejiang University School of Medicine (4 June 2026; approval No.2026-011). Findings will be disseminated through peer-reviewed publications and academic conferences.  Trial Registration: Registered in the International Traditional Medicine Clinical Trial Registry (ITMCTR) with the registration number ITMCTR2026002224 (https://itmctr.ccebtcm.org.cn/, 31 August 2026).
SN  - 1178-7090
ER  -